Evidence from numerous studies shows that emerging markets have far more poor quality drugs than western markets. There are many reasons for this, but one reason, investigated in this paper, is the possibility that smaller, often privately-owned, pharmacies take greater risks with drug...

In this paper, the authors document the complex issues facing the FDA in assessing the quality of generic drugs. They conclude that increased transparency as well as the updating of FDA bioequivalence standards may be important to overcome some of these challenges.

This book examines the effects of government intervention on the operations of the freight transportation industry.

The authors consider whether any special circumstances justify departure from free trade in telecommunications equipment.

Carefully researched and comprehensive--a masterful road map to U.S. trade policy and trade law.